Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Merrill RM, Kelley TA, Cox E, Layman AB, Layton BJ, Lindsay R. Factors and barriers influencing influenza vaccination among students at Brigham Young University. Med Sci Monit. 2010 Feb;16(2):PH29-34.